1,7-phenanthroline has been researched along with Human T-lymphotropic Virus 1 Infection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, M; Ishitsuka, K; Kinjo, J; Nakano, D; Okabe, H; Okawa, M; Tamura, K; Tsuchihashi, R | 1 |
1 other study(ies) available for 1,7-phenanthroline and Human T-lymphotropic Virus 1 Infection
Article | Year |
---|---|
Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (IV): phenanthroindolizidine alkaloids from Tylophora tanakae leaves.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; HTLV-I Infections; Humans; Indolizines; Leukemia-Lymphoma, Adult T-Cell; Phenanthrolines; Plant Leaves; Structure-Activity Relationship; T-Lymphocytes; Tylophora | 2015 |